Company Profile for Stem Cell Stock, Vitro Diagnostics, Inc. dba Vitro Biopharma (OTCQB: VODG)

POINT ROBERTS, Wash., May 5, 2011 - www.InvestorIdeas.com, a leader in investor research including biotech and stem cell stocks, issues the company profile for stem cell company, Vitro Diagnostics, Inc. dba Vitro Biopharma (OTCQB: VODG) for investors following the sector.

About Vitro Diagnostics, Inc. (OTCQB: VODG)
Vitro Diagnostics, Inc. dba Vitro Biopharma (OTCQB: VODG) (http://www.vitrobiopharma.com), owns U.S. patents for production of FSH, immortalization of pituitary cells, and a cell line that produces beta islets for use in treatment of diabetes. Vitro also owns a pending international patent for generation of pluripotent stem cells. Vitro's mission is "Harnessing the Power of Cells™" for the advancement of regenerative medicine to its full potential. Vitro operates within a modern biotechnology manufacturing, R&D and corporate facility in Golden, Colorado. Vitro manufactures and sells "Tools for Stem Cell and Drug Development™", including human mesenchymal stem cells and derivatives, optimized media for stem cell self-renewal and lineage-specific differentiation. Vitro recently formed a strategic alliance with HemoGenix®, Inc. (http://www.hemogenix.com/) to jointly manufacture and distribute Lumenesc™ and LumiSTEM™ quantitative assays for determination of stem cell quality, potency and response to toxic agents.
Recent News;
Stem Cell Stock Vitro (OTCQB: VODG) Announces Progress in the Achievement of Profitability
Revenue Increase Due to Licensing Fertility Drug Patents, Products and Technology
GOLDEN, Colo. - May 3, 2011 (Investorideas.com Newswire) - Vitro Diagnostics, Inc. (OTCQB:VODG), dba Vitro Biopharma, announced progress and achievement of key financial goals in the transformation of the Company from a research operation to a profitable commercial operation with sustained earnings growth. Income was recently increased by $200,000 through license fees obtained by licensing our fertility drug patents, products and technology. This infertility treatment technology was developed previously and is no longer a primary operational goal as the Company is now focused on commercialization of stem cell products and technology. Thus, the recent license of this intellectual property allows the Company to monetize previously written-off assets through income from license fees and potential sales royalties while also pursuing additional product revenues through sales of its stem cell products.
Full News: http://www.investorideas.com/CO/VODG/news/2011/05031.asp
More info:
Visit the VODG company profile on Investorideas.com  
Visit the Biotech stocks directory at Investorideas.com
Request news and info on VODG
Sign up for the free investor news letter and get stock alerts in leading sectors!
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising .
Disclosure: VODG is a paid showcase stem cell stock on Investorideas.com (one month $1000)
www.InvestorIdeas.com/About/Disclaimer.asp
Safe Harbor Statement
This release contains certain "forward-looking statements" relating to the business of the Company and its subsidiary companies. These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions. Such forward-looking statements involve known and unknown risks and uncertainties that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors.
www.Investorideas.com
Dawn Van Zant: 800-665-0411 - dvanzant@investorideas.com
Source - Investorideas.com

Security and Defense Stock Update; Visualant (OTCBB:VSUL) Revenues Jump 100% for the Three Months Ended March 31, 2011

SEATTLE - May 5, 2011 (Investorideas.com Defense Newswire) - Summary of Operating Results from Continuing Operations
Visualant, Inc. (OTCBB: VSUL) announced the following results for the three months ended March 31, 2011, as compared to the three months ended March 31, 2010:

• Revenues- increased 100% to $2,866,000 from $0.
• Gross profit- increased 100% to $345,000 from $0.
• Net loss was $520,000 as compared to $231,000 for the same quarter in 2010. The loss was due to costs to expand its investor base and annual share issuances to directors.
• Net loss per share was $.01 per share as compared to $.01 per share from the same quarter in 2010.
• Cash flow provided by operations was $928,000 as compared to $(145,000).

Key Accomplishments

• Successfully licensed the Visualant Spectral Pattern Matching (�SPM�) Technology for environmental applications to Javelin LLC.
• Entered into a Letter of Intent to acquire Eagle Technologies, Inc. and commenced due diligence with an anticipated closing during the three months ended June 30, 2011.
• Entered into a consulting agreement with Lance Gima, retired former head of the State of California Forensics' Laboratory to pursue forensic applications of the SPM technology.
• Secured additional institutional funding from Seaside 88 Advisors LLC.
• Continued development of Visualant's SPM technology and demonstrated the technology at leading industry trade shows.

The company's CEO, Ron Erickson, said, �We are pleased to announce that our 100% subsidiary, TransTech Systems, Inc., reported strong revenues for the three months ended March 31, 2011. With their continuing growth through their 300 plus dealer channel and direct relationship with major clients, we expect TransTech to continue to report strong revenues. In the coming months we should see further revenue growth with our planned acquisitions and the movement into the marketplace of our SPM technology.�
About Visualant, Inc.
Visualant, Inc. (OTCBB: VSUL) develops low-cost, high speed, light-based security and quality control solutions for use in homeland security, anti-counterfeiting, forgery/fraud prevention, brand protection and process control applications. Our patent-pending technology uses controlled illumination with specific bands of light, to establish a unique spectral signature for both individual and classes of items. When matched against existing databases, these spectral signatures allow precise identification and authentication of any item or substance. This breakthrough optical sensing and data capture technology is called Spectral Pattern Matching ("SPM"). SPM technology can be miniaturized and is easily integrated into a variety of hand-held or fixed mount configurations, and can be combined in the same package as a bar-code or biometric scanner.
Through its wholly owned subsidiary, TransTech Systems, Inc., the Company provides security and authentication solutions to security and law enforcement markets throughout the United States.
Safe Harbor Statement
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: This press release contains forward-looking statements (within the meaning of Section 27a of the Securities Act of 1933 and Section 21e of the Securities Exchange Act of 1934) regarding us and our business, financial condition, results of operations and prospects. Forward-looking statements in this press release reflect the good faith judgment of our management and are based on facts and factors currently known to us. Forward-looking statements are subject to risks and uncertainties, and actual results and outcomes may differ materially from the results and outcomes discussed in the forward-looking statements as a result of either the matters set forth or incorporated in this press release generally or certain economic and business factors, some of which may be unknown to and/or beyond the control of Visualant, Inc. Specifically, we are exposed to various risks related to our need for additional financing to support our technology development, the sale of a significant number of our shares of common stock could depress the price of our common stock, acquiring or investing in new businesses and ongoing operations, we may incur losses in the future and the market price of our common stock may be volatile. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. We do not undertake, and we expressly disclaim, any obligation to revise or update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of the press release.
Contact:
Visualant, Inc.:
Lynn Felsinger
206 903 1351
Lynn@visualant.net
Investor Relations
Paul DeRiso
Core Consulting Group
925-465-6088
paul@coreconsultingroup.com
Visualant, Inc. (OTCBB:VSUL) Featured showcase company on Investorideas.com and related security portals and blogs
Visit the showcase page: http://www.investorideas.com/CO/VSUL/
Disclosure and Disclaimer: Visualant, Inc. (OTCBB:VSUL) is a paid advertising featured showcase company on Investorideas.com and related security portals and blogs.
(1500 per month and $five thousand per month in restricted 144 shares)

Mining Stocks News Alert; YALE (TSX-V: YLL) STARTS GEOPHYSICS PROGRAM AT LOS AMOLES


May 5, 2011 (Investorideas.com Mining stocks Newswire) - Yale Resources Ltd. (TSX-V: YLL and Frankfurt: YAB) is pleased to report a geophysics program has been started on the Los Amoles Property located in central Sonora State. Work at Los Amoles is being done by Yale on behalf of Sonora Resources Ltd. (previously Nature's Call), which has an option to earn a 70% interest in the property.

The geophysics will consist of both IP and Magnetic susceptibility and cover a nine (9) square kilometer area with 28 line kilometres of grid. This area will cover the main 1.0 by 2.5 km target area that has previously been mapped and sampled as well as prospective land to the southwest that is known to contain additional historic workings.
Previous mapping has successfully defined a vein system that has been traced on surface for approximately 800 metres along strike (see news release dated Feb. 15, 2011) with highlight samples including:

• 2.0 metres grading 0.63 g/t gold and 698.6 g/t silver
• 6.0 metres averaging 0.33 g/t gold and 226.6 g/t silver
• including 2.0 metres grading 0.63 g/t gold and 497.3 g/t silver
• 1.0 metres grading 0.33 g/t gold and 496.8 g/t silver
• Dump material grading 0.24 g/t gold and 1,027.5 g/t silver

To date, greater than 45 historic workings and greater than 20 gold/silver veins have been identified within approximately 60% of the El Rosario target area that measures 1.0 by 2.5 kilometres. Another stage of fieldwork is planned in order to map and sample the remaining areas within the El Rosario target. This work will be done in advance of geophysics, which in turn, will be done to delineate priority locations for drilling.
About the Los Amoles Property:
The early stage wholly owned 16.3 square kilometre Los Amoles Property is located approximately 150 kilometres northeast of the Hermosillo, Sonora State, Mexico. The property is 10 kilometres northeast of the La Caridad Mine, operated by Grupo Mexico, which is one of the largest mining and processing complexes in Mexico.
Sonora Resources has an option to earn a 70% interest in the property by paying to Yale US $ 50,000 (received), spending US $ 900,000 on exploration expenditures and issuing 1,000,000 shares (200,000 have been received) to Yale over three years.
Work performed to date by Yale has concentrated on an area (the Rosales area) that is on the south eastern edge of a 4.0 by 2.75 km regional magnetic anomaly. Yale's interpretation is that the Rosales area represents silver-lead +/- gold veins that are distal to a porphyry system. The potential for this regional anomaly to reflect a buried porphyry has yet to be tested. Many of Sonora's most significant porphyry deposits are located within 70 km of the Los Amoles property.
Samples from Los Amoles were prepared and analyzed by IPL Inspectorate in their facilities in Mexico and Vancouver, respectively. Samples generally consisted of 1-3 kg of material. Gold and silver analyses were performed by 30 gram fire assay with an AA finish. Samples with greater than 100 g/t silver were re-assayed using gravimetric methods.
Ian Foreman, P.Geo., is Yale Resources' Qualified Person, as defined by National Instrument 43-101. The Los Amoles property is an early stage project that requires additional sampling and geological mapping to fully determine the project's potential.
On behalf of the Board,
"Ian Foreman"
Ian Foreman, P.Geo.
President

For additional information on Yale Resources please call the Company at 604-678-2531.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Statements in this press release, other than purely historical information, including statements relating to the Company's future plans and objectives or expected results, may include forward-looking statements. Forward-looking statements are based on numerous assumptions and are subject to all of the risks and uncertainties inherent in resource exploration and development. As a result, actual results may vary materially from those described in the forward-looking statements.

Statements in this press release, other than purely historical information, including statements relating to the Company's future plans and objectives or expected results, may include forward-looking statements. Forward-looking statements are based on numerous assumptions and are subject to all of the risks and uncertainties inherent in resource exploration and development. As a result, actual results may vary materially from those described in the forward-looking statements.
About Yale Resources:
Yale Resources is an exploration and development company concentrating in northwestern Mexico. Utilizing the joint venture business model, Yale is able to maximize its exposure to discovery while minimizing exploration risk. At the same time Yale continues to work on its non-optioned properties as well as reviewing new projects. Yale has four projects under option to value added partners with commitments for approximately $1.0M in expenditures during the next 12 months.
Contact:
Yale Resources Ltd.
Ian Foreman
604-678-2531

Visit the YLL showcase profile at Investorideas.com
Request News and Info on YLL
Disclosure, Disclaimer/ YLL is a paid advertising client on Investorideas.com and our mining portals.

Mining Stocks; Soltera Mining Corp. (OTC:SLTA.PK; FRANKFURT:SN7): El Torno Vein Gold Sampling Results

JUJUY, ARGENTINA - May 5, 2011 (Investorideas.com mining stocks newswire) - Dr. Fabio Montanari, President and CEO of Soltera Mining Corp. (OTCPK:SLTA, FRANKFURT: SN7) (www.solteramining.com), is pleased to announce the exciting results of a reconnaissance hardrock gold sampling program carried out last month (April 2011).

Following the previously reported sampling program for eluvial (surface weathered) gold, Soltera immediately began to focus on the two major gold targets at El Torno: the large gold-bearing vein systems that cross the license area; and the potential open-pit areas with dispersed gold. Both types of target were outlined by the 2008 geochemical surveys and Soltera opted to start with the vein system.
The first step was a reconnaissance survey of the bedrock and vein mineralization within a short (300 meter) stretch of the main vein system and a smaller area half a kilometer to the northwest. A total of 44 samples were collected from old trenches (probably dug by Codelco and Penoles) or from rock outcrops. Thirty-nine samples were 1 or 1.5 meter length channels; five were rock-chip. The samples, mainly between 2 kg and 2.5 kg in weight, were sent to an internationally recognized laboratory for fire assay.
The results are excellent. From a total of 44 samples analyzed, 17 showed more than 1 g/t Au including:

• 6.5 meters with between 6.2 and 8.8 g/t Au,
• 1 meter at 14.95 g/t Au,
• 1 meter at 20.9 g/t Au, and
• 1.5 meters at 376 g/t Au.
• The mean value of the 17 samples containing more than 1 g/t Au (with the 376 g/t Au cut to 100 g/t Au) is 11 g/t Au.

Most of the gold-rich samples were from along the western side of the main vein system, but some were in smaller vein systems to the northwest.
The survey has confirmed the existence of rich gold mineralization in a zone flanking the main vein system, as indicated by the 1997 Puma drilling program which was adjacent to the sampled area. This zone is at least 6 meters thick in the area tested and our results also show mineralization that has not previously been recognized within parts of the 14-meter thick main vein system. The results confirm the importance of the geochemical anomalies as guidelines to mineralization.
The reconnaissance survey covered only a small part of the vein system and the geochemically anomalous areas and Soltera is now planning a program of mapping and sampling to cover them all in detail. The objective will be to provide basic data and guidelines for the geophysical surveys and drilling programs over the main targets.
Safe Harbor Statement: Certain statements contained herein are "forward-looking" statements (as such term is defined in the Private Securities Reform Act of 1995). Because such statements include risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Information or opinions in this document are presented solely for informative purposes and are not intended nor should be construed as investment advice. We encourage you to carefully review the Company with your investment advisor and verify any information that is important to your investment decision.
Contacts:
Soltera Mining Corp.
Fabio Montanari
President/CEO
1-888-768-5552
info@solteramining.com
www.solteramining.com
Disclosure: SLTA is a paid advertising client on Investorideas.com and our mining portals.

Wind Energy News; Clean Wind Energy Tower (OTCBB: CWET) Files "Atmospheric Energy Extraction Devices & Methods" Patent for Wind Tower

ANNAPOLIS, MD - May 5, 2011 (InvestorIdeas.com Newswire) - Clean Wind Energy Tower, Inc. (OTCBB: CWET), a clean energy company developing Downdraft Towers, reports it has filed with the United States Patent & Trademark Office "A Petition to Make Special Under the Accelerated Examination Program," a patent application titled Atmospheric Energy Extraction Devices and Methods.

The application covers the addition of specific external design components, physical structure and systems that both substantially enhances structural integrity of the tower and captures wind directly striking the external vertical surfaces of the downdraft tower from any direction, beyond those winds already induced into the internal tube of the tower, and also enhances slow moving air to create downburst winds, substantially increasing total power generation of a single tower unit.
John W. Hanback, Chief Technology Officer, stated, "This patent application is the second of many, as we previously stated, that we would file in order to protect our innovative technological approach to producing clean power from the wind, and also to continue to substantiate the value of our technology. As with our previous application, the claims embodied within this application are also directed toward creating very efficient power generation at low capital costs."
Ronald W. Pickett, Chairman and CEO, stated, "We believe this patent application provides enormous benefits and advantages to our Dual Renewable Energy solution by creating an additional multiple to our power base during the variety of atmospheric fluctuations in temperature, humidity and wind direction over the course of a season."
About Clean Wind Energy, Inc. (OTCBB: CWET)
Clean Wind Energy, Inc., a wholly owned subsidiary of Clean Wind Energy Tower, Inc, is designing and preparing to develop, and construct large "Downdraft Towers" that use benevolent, non-toxic natural elements to generate electricity and clean water economically by integrating and synthesizing numerous proven as well as emerging technologies. In addition to constructing Downdraft Towers in the United States and abroad, the Company intends to establish partnerships at home and abroad to propagate these systems and meet increasing global demand for clean water and electricity. Clean Wind has assembled a team of experienced business professionals, engineers and scientists with access to the breakthrough energy research upon which this technology is founded and the proven ability to bring the idea to market. Clean Wind has filed several patents that the Company believes will further enhance this potentially revolutionary technology.
Cautionary Note Regarding Forward-Looking Statements
Statements included in this release may constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such statements involve a number of risks and uncertainties such as competitive factors, technological development, market demand and the Company's ability to obtain new contracts and accurately estimate net revenues due to variability in size, scope and duration of projects, and internal issues in the sponsoring client. Further information on potential factors that could affect the Company's financial results, can be found in the Company's various filings with the Securities and Exchange Commission (SEC).
Contact
Clean Wind Energy, Inc.
1997 Annapolis Exchange Parkway Suite 300
Annapolis, Maryland 21401
Phone: 410-972-4713
E-mail: Info@cwetower.com
www.cleanwindenergytower.com
Investor Relations
Jody Janson
Phone: (855) 848-6937
Email: ir@cwetower.com

Visit the CWET showcase profile at Investorideas.com
Request News and Info on CWET
Disclosure, Disclaimer/ CWET is a paid advertising client on Investorideas.com and our Renewable Energy portals.

Electric Car Stocks News Alert; EVCARCO, Inc. (OTCBB: EVCA) Signs Contract to Sell SIRIUS New Electric Vehicles

FT. WORTH, TX � May 3, 2011 (Investorideas.com renewable energy/green newswire) - EVCARCO, Inc. (OTCBB:EVCA) (Pinksheets:EVCA) announced today that it has signed a retailer agreement to sell SIRIUS electric vehicles. The SIRIUS brand is manufactured by Nanchang Freedom Technology Limited located in Nanchang, China, a subsidiary of Jiangling Motors Group Co. Of the many electric vehicle products manufactured by Nanchang, the SIRIUS line is the most appealing to EVCA and includes mini-trucks, mini-vans, high speed vans and cars.

Mack Sanders, CEO of EVCARCO, remarked, "We have looked diligently over the last quarter at several quality manufacturers and we are excited to add this product line to our dealership commercial offerings. We expect to receive the first vehicle on May 5th, 2011."
Nanchang Freedom Technology Limited Company was founded in December 2006 and specializes in development and manufacture of New Energy Vehicles, and New Energy Vehicles' Power Train System. It is a subsidiary of Jiangling Motors Group Co. Jiangling Motor, a joint venture with Ford, in the U.S., and Isuzu, in Japan, is one the largest light commercial vehicle manufacturers in China. The Company manufactures high quality, totally green and environment-friendly vehicles and has developed highway speed and low speed electric vehicles after years of independent R&D. Some EVs are QQ Electric Passenger Car, Landwind Fashion Electric Passenger Car, Ford Transit Electric Commercial Van, SIRIUS series of Electric Mini Truck, Electric Mini Van, Electric ATVs, and Electric Environmental Sanitation Vehicles (mini truck) dumper truck and detachable container garbage collector.
SIRIUS Product Link: http://www.evcarco.com/SiriusProductLine.pdf
For more information on EVCARCO, Inc., please view: www.evcarco.com. Shareholder inquiries should be directed to (972) 571-1624.
EVCARCO, Inc. is the first automotive retail group dedicated to deploying a coast-to-coast network of environmentally friendly franchised dealerships and vehicles. EVCARCO is bringing to market the most advanced clean technologies available in plug-in electric, alternative fuel, and pre-owned hybrid vehicles. EVCARCO -- Future Driven®
This Press Release contains certain forward-looking statements that involve substantial risks and uncertainties, including, but not limited to, the results of ongoing clinical studies, economic conditions, product and technology development, production efficiencies, product demand, competitive products, competitive environment, successful testing and government regulatory issues. Additional risks are identified in the company's filings made with the Securities and Exchange Commission.
Contact:
Investor Relations Contact:
Jack Eversull
The Eversull Group, Inc.
972-571-1624
214-469-2361 fax

Visit the EVCA showcase profile at Investorideas.com
Request News and Info on EVCA
Disclosure, Disclaimer/ EVCA is a paid advertising client on Investorideas.com and our renewable energy portals (500,000 144 shares).

Mining and Metals Stocks Online Mining Investor Conference adds Siddharth Rajeev of Fundamental Research to List of Industry Speakers

May 4 2011 - www.Investorideas.com and www.SmallCapVoice.com, leaders in small cap investor research announce new speakers and media sponsors for the upcoming online investor conference, ‘Follow the Money in Mining and Metals’, May 25 th and 26 th. Mr. Siddharth Rajeev Of Fundamental Research Corp will join Eric Coffin from Hard Rock Analyst, Peter Grandich, Lawrence Roulston and Stephen Whiteside of TheUpTrend.com.

Mining tocks Currie Rose Resources Inc. (TSX.V: CUI) (OTC: CUIRF),Strategic Resources (TSXV: UVR), Yale Resources Ltd. (TSX-V - YLL and Frankfurt - YAB) and Running Fox (TSX-V: RUN) (US OTC: RFXRF) ( FRANKFURT: C8Q) will be presenting a 10-15 minute overview for investors.
Media sponsors include the Streetwise Reports / Gold Report, mining investor sites Mine Snooper www.minesnooper.com , International Mining Research Inc (www.internationalminingresearch.com ) and the investor research magazine, the Opportunist.
The online mining conference, Follow the Money in Mining and Metals, will be held May 25 th and 26. Industry Speakers include Eric Coffin from Hard Rock Analyst, Peter Grandich, Lawrence Roulston and Stephen Whiteside of TheUpTrend.com.
The online conference is free to investors with login registration. Investors will have the opportunity to hear some of the best in the industry provide insight on the future of mining stocks.
Investor registration:
The presentations will be an audio format with PowerPoint, averaging 10-15 minutes in length.
The event will be pre-recorded and go live May 25 th starting at 9:00 a.m. EST. It will be archived for three months and available with login. The conference pages will be featured for investors at both Investorideas.com and SmallCapvoice.com.
Learn More about the Mining Conference
http://www.investorideas.com/MSS/Conference.asp
Free Investor Sign-Up
http://www.smallcapvoice.com/ii_scv/investor-signup.html
Public Company Sign-Up
http://www.smallcapvoice.com/ii_scv/company-signup.html
New Speaker Bio
Siddharth Rajeev, B.Tech (Electronics Engineering), MBA (Finance), CFA Vice-President - Head of Research for Fundamental Research Corp
http://www.researchfrc.com
At Fundamental Research Corp, Sid heads the research department which covers over 150 small and micro cap companies and 15 exempt market/private issues from a broad array of industries including Energy, Mining, Real Estate and Technology. He also manages the FRC list of Top Picks, which are the stocks under coverage which he has the highest conviction level about. These picks have historically helped the firm finish strong in various third party analyst performance rankings. Sid holds a Bachelor of Technology degree in Electronics Engineering from Cochin University of Science & Technology, and an MBA (Finance) from The University of British Columbia. He is a CFA Charterholder, and has completed studies in exploration and prospecting at the British Columbia Institute of Technology. Sid is sought by the media for commentary on the valuation of small cap stocks and industries he covers. He is also co-author of two online courses including the very successful "Evaluation of Junior Mining Companies for Investment Purposes" which has evolved into classroom courses, seminars, and is in demand at investment conferences across North America.
Mining Stocks:
Running Fox (TSX-V: RUN) ( US OTC: RFXRF) ( FRANKFURT: C8Q)
Running Fox is a Canadian growth-oriented resource company with mineral projects including US uranium and Canadian gold properties, oil and gas assets, and oilfield service operations.
Contact
Steven Schurman
Running Fox Resource Corp.
1 604 725 8868
www.foxgold.ca
Yale Resources Ltd. (TSX-V - YLL and Frankfurt - YAB)
Yale Resources Yale Resources Ltd. is an exploration and development company building value utilizing the Project Generator business model. With its Mexican operations based out of Hermosillo, Sonora, Yale is utilizing its extensive Mexican network to identify, acquire and advance projects of merit. Yale's partners are scheduled to spend greater than $1,000,000 on exploration on the Company's properties over the next 12 months.
Contact
Ian Foreman
info@yaleresources.com
www.yaleresources.com
Currie Rose Resources Inc. (TSX.V: CUI) (OTC: CUIRF)
Currie Rose Resources Inc. is a gold exploration company listed on the Toronto Venture Exchange under the symbol CUI-V, Frankfurt Exchange CDV, and U.S. OTC Market symbol CUIRF. The main focus is the Company's gold exploration projects in The Lake Victoria Gold Fields in Tanzania
IR contact
Harold Smith
harold@currierose.com
www.currierose.com
Strategic Resources (TSXV: UVR)
Strategic Resources is a Canadian based junior exploration company with uranium/vanadium exploration projects in Catron County, New Mexico, Rare Earth exploration projects in Lincoln County and Socorro County, New Mexico and a Lithium project in Malheur County, Oregon.
www.strategicresourcesinc.ca
IR Contact
Malcolm Bucholtz
Supercyclereport@gmail.com
About www.InvestorIdeas.com: Investor Ideas that Can Change the World
Investor Ideas is a global financial media online destination specialized in sector investing content including mining and energy stocks.
About SmallCapVoice.com, Inc.: Specializing in Covering Small Cap Stocks & Providing Small Cap Investor Relations
Recognized corporate investor relations firm SmallCapVoice.com, Inc. is known for its ability to help emerging growth companies build a following among retail and institutional investors.
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. www.InvestorIdeas.com/About/Disclaimer.asp
Disclosure: YLL is also a featured showcase stock on Investorideas.com
Learn more: http://www.investorideas.com/About/News/Clientspecifics.asp
For info on presenting as a public company, speaker or media sponsor contact

Cali Van Zant: 800-665-0411 - cvanzant@investorideas.com
Stuart T. Smith CEO
512-267-2430
ssmith@smallcapvoice.com
Source - Investorideas.com, SmallCapVoice.com

Oil and Gas Stocks News; American Petro-Hunter (OTCBB: AAPH) Begins Multi-Stage Surge Frack at North Oklahoma Project


SCOTTSDALE, AZ � May 4, 2011 (Investorideas.com energy newswire) - American Petro-Hunter, Inc. (OTC.BB:AAPH) ("American Petro-Hunter" or the "Company") announced today the commencement of a "multi-stage surge frack" regarded as the final event in the completion process at the NOS227 well prior to the onset of commercial oil production.

The fracture stimulation ("frack") program is a newly designed approach intended to break apart the reservoir allowing for a significant increase in the flow of oil. The process has proven to be highly effective in dramatically increasing production from the Mississippi formation elsewhere in the area. Currently, all requisite equipment has arrived onsite and efforts have commenced.
As previously reported, analogous vertical wells located nearby and to the north of NOS227 and having undergone an identical stimulation program have paid out in less than 90 days. The new completion technologies offer the potential to deliver vastly higher production through the use of the latest enhanced reservoir stimulation technologies. The "multi-stage surge frack" is a proven advanced technology that has delivered excellent results regionally and was chosen as the approach presenting the best potential yield results given the geology of the location. The frack of the well will stimulate 85 feet of the pay in the Mississippi Formation and American Petro-Hunter has targeted an initial production rate (I.P.R.) post-frack of 300 BPOD.
American Petro-Hunter has a 50% interest in the well and production from NOS227 will be sold alongside output from the No. 1 and NOJ26 wells to Sunoco, the regional purchaser. West Texas Intermediate Crude today has recently been priced at $112 per barrel and continues to rise based on instability in the Middle East.
About American Petro-Hunter, Inc. (OTCBB: AAPH)
The Company is a goal-oriented exploration and production (E&P) Company aiming to become an intermediate level oil and gas producer within 12 months. The Company is in production at the Poston Project in Trego County Kansas with new drilling activity and production underway at the North Oklahoma Oil Project. With the achievable target of becoming a 1000 BOE producer as our goal, American Petro-Hunter is actively on the "hunt" for domestic petroleum assets. Visit us at: www.americanpetrohunter.com
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of our exploration program at our properties and any anticipated future production. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with petroleum exploration and development stage exploration companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-KSB for the most recent fiscal year, our quarterly reports on Form 10-QSB and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
ON BEHALF OF THE BOARD
American Petro-Hunter, Inc.
Robert McIntosh
President & C.E.O.
To find out more about American Petro-Hunter, Inc. (OTC.BB:AAPH), visit our website at www.americanpetrohunter.com
Contact:
Investor Relations:
Mountainview IR Services, Inc.
1-888-521-7762
investors@americanpetrohunterinc.com

Visit the AAPH showcase profile at Investorideas.com
Request News and Info on AAPH
Disclosure, Disclaimer/ AAPH is a paid advertising client on Investorideas.com.
American Petro-hunter Inc. (AAPH.OB) Oct 2010 - one month showcase energy stock on Investorideas.com and energy portals and blogs (three thousand per month)

Wind Energy Stocks; Clean Wind Energy Tower, Inc. (OTCBB: CWET) Files "Atmospheric Energy Extraction Devices & Methods" Patent

ANNAPOLIS, MD - May 4, 2011 (InvestorIdeas.com Newswire) - Clean Wind Energy Tower, Inc. (OTCBB: CWET) (the "Company") announced that the Company had filed with the United States Patent & Trademark Office "A Petition to Make Special Under the Accelerated Examination Program," a patent application titled Atmospheric Energy Extraction Devices and Methods. The application covers the addition of specific external design components, physical structure and systems that both substantially enhances structural integrity of the tower and captures wind directly striking the external vertical surfaces of the downdraft tower from any direction, beyond those winds already induced into the internal tube of the tower, and also enhances slow moving air to create downburst winds, substantially increasing total power generation of a single tower unit.

John W. Hanback, Chief Technology Officer, stated, "This patent application is the second of many, as we previously stated, that we would file in order to protect our innovative technological approach to producing clean power from the wind, and also to continue to substantiate the value of our technology. As with our previous application, the claims embodied within this application are also directed toward creating very efficient power generation at low capital costs."
Ronald W. Pickett, Chairman and CEO, stated, "We believe this patent application provides enormous benefits and advantages to our Dual Renewable Energy solution by creating an additional multiple to our power base during the variety of atmospheric fluctuations in temperature, humidity and wind direction over the course of a season."
About Clean Wind Energy, Inc. (OTCBB: CWET)
Clean Wind Energy, Inc., a wholly owned subsidiary of Clean Wind Energy Tower, Inc, is designing and preparing to develop, and construct large "Downdraft Towers" that use benevolent, non-toxic natural elements to generate electricity and clean water economically by integrating and synthesizing numerous proven as well as emerging technologies. In addition to constructing Downdraft Towers in the United States and abroad, the Company intends to establish partnerships at home and abroad to propagate these systems and meet increasing global demand for clean water and electricity. Clean Wind has assembled a team of experienced business professionals, engineers and scientists with access to the breakthrough energy research upon which this technology is founded and the proven ability to bring the idea to market. Clean Wind has filed several patents that the Company believes will further enhance this potentially revolutionary technology.
Cautionary Note Regarding Forward-Looking Statements
Statements included in this release may constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such statements involve a number of risks and uncertainties such as competitive factors, technological development, market demand and the Company's ability to obtain new contracts and accurately estimate net revenues due to variability in size, scope and duration of projects, and internal issues in the sponsoring client. Further information on potential factors that could affect the Company's financial results, can be found in the Company's various filings with the Securities and Exchange Commission (SEC).
Contact
Clean Wind Energy, Inc.
1997 Annapolis Exchange Parkway Suite 300
Annapolis, Maryland 21401
Phone: 410-972-4713
E-mail: Info@cwetower.com
www.cleanwindenergytower.com
Investor Relations
Jody Janson
Phone: (855) 848-6937
Email: ir@cwetower.com

Visit the CWET showcase profile at Investorideas.com
Request News and Info on CWET
Disclosure, Disclaimer/ CWET is a paid advertising client on Investorideas.com and our Renewable Energy portals.

Biotech and Pharma News; BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) To Present at JMP Securities Research Conference

LINCOLNSHIRE, Ill. - May 4, 2011 (Investorideas.com newswire) - BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) will be presenting at The JMP Securities Tenth Annual Research Conference. The event will take place from May 9, through May 11, 2011, at The Ritz-Carlton, San Francisco.

Stephen M. Simes, BioSante's president & CEO, will speak on May 9, 2011 at 3:00 PM PT. He will provide an overview of the company, as well as an update on the LibiGel® (testosterone gel) Phase III clinical development program. A live audio webcast of Mr. Simes' remarks may be accessed at: http://www.wsw.com/webcast/jmp13/bpa/. The webcast will be archived approximately three hours after the live event and will be available for 90 days.
About BioSante Pharmaceuticals, Inc.
BioSante is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. BioSante's lead products include LibiGel® (transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD) which is in Phase III clinical development under a U.S. Food and Drug Administration (FDA) Special Protocol Assessment. BioSante also is developing a portfolio of cancer vaccines, four of which have been granted Orphan Drug designation, and are currently in several Phase II clinical trials. Other products in development are Bio-T-Gel™, a testosterone gel for male hypogonadism licensed to Teva Pharmaceuticals and an oral contraceptive in Phase II clinical development using BioSante patented technology. The company also is seeking opportunities for its other technologies. Additional information is available online at: www.biosantepharma.com.
Forward-Looking Statements
To the extent any statements made in this news release deal with information that is not historical, these are forward-looking statements under the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about BioSante's plans, objectives, expectations and intentions with respect to future operations and products, the timing of anticipated regulatory submissions and other statements identified by words such as "will," "potential," "could," "can," "believe," "intends," "continue," "plans," "expects," "anticipates," "estimates," "may," other words of similar meaning or the use of future dates. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Uncertainties and risks may cause BioSante's actual results to be materially different than those expressed in or implied by BioSante's forward-looking statements. For BioSante, particular uncertainties and risks include, among others, the difficulty of developing pharmaceutical products, obtaining regulatory and other approvals and achieving market acceptance; the marketing success of BioSante's licensees or sublicensees; the success of clinical testing; and BioSante's need for and ability to obtain additional financing. More detailed information on these and additional factors that could affect BioSante's actual results are described in BioSante's filings with the Securities and Exchange Commission, including its most recent annual report on Form 10-K and subsequent quarterly reports on Form 10-Q. All forward-looking statements in this news release speak only as of the date of this news release. BioSante undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
Contact:
BioSante Pharmaceuticals
For Investors:
The Trout Group LLC
Tricia Swanson
(646) 378-2953
tswanson@troutgroup.com
or
For Media:
McKinney/Chicago
Alan Zachary
(312) 944-6784 ext. 316
azachary@mckinneychicago.com

Disclosure, Disclaimer/ BPAX is a paid advertising client on Investorideas.com (1000 per month).

Stem Cell Stock Vitro (OTCQB: VODG) Announces Progress in the Achievement of Profitability

GOLDEN, Colo. � May 3, 2011 (Investorideas.com Newswire) - Vitro Diagnostics, Inc. (OTCQB:VODG), dba Vitro Biopharma, announced progress and achievement of key financial goals in the transformation of the Company from a research operation to a profitable commercial operation with sustained earnings growth. Income was recently increased by $200,000 through license fees obtained by licensing our fertility drug patents, products and technology. This infertility treatment technology was developed previously and is no longer a primary operational goal as the Company is now focused on commercialization of stem cell products and technology. Thus, the recent license of this intellectual property allows the Company to monetize previously written-off assets through income from license fees and potential sales royalties while also pursuing additional product revenues through sales of its stem cell products.

Vitro's stem cell products provide key tools needed to expand emerging stem cell technology into viable clinical products to treat a vast array of conditions resulting from cellular degeneration or injury, such as heart disease, stroke and Alzheimer's disease. The Company's products include cell culture media used to expand and differentiate stem cells prior to transplantation and in research applications. This market alone is estimated to be $1.2 billion in 2015 1. A leading global stem cell company and prospective customer has recently reported superior performance of one of the Company's media products in an extensive comparison with competing products. Sales of stem cell media is a primary focus for accelerated revenue generation. Our distribution and marketing plan currently targets select distributors together with direct sales to key accounts representing substantial sales volume. We are now in discussions and product evaluations with distributors and key initial accounts. Numerous studies by the Company and other independent groups have shown strong competitive advantages of the Company's stem cell media. We intend to leverage our highly competitive media products into aggressive penetration of this emerging market. Management projects achievement of profitable operations by the end of its current fiscal year (10-31-11) or sooner.
To sustain future revenues and earnings growth, the Company intends to expand and improve its current product offering of tools for stem cell research and is now developing clinical grade products to support clinical trials and eventual therapeutic applications of stem cells. Furthermore, the Company intends to identify synergistic M&A candidates with existing product sales and profits to provide rapid growth of revenue and earnings. Early stage discussions are now underway with a privately held stem cell firm regarding a business combination with the Company.
Current liabilities have also been reduced by $250,000, through fees obtained from recent patent out-licenses and debt refinancing activities. Operating expenses have also been reduced by approximately $100,000 (37%) per year through debt service expense reduction, reduction of interest expenses, and executive salary reduction. These activities enable a more rapid turn-around and improve shareholder's equity.
About Vitro Diagnostics, Inc.
Vitro Diagnostics, Inc. dba Vitro Biopharma (OTCQB: VODG) (http://www.vitrobiopharma.com), owns U.S. patents for production of FSH, immortalization of pituitary cells, and a cell line that produces beta islets for use in treatment of diabetes. Vitro also owns a pending international patent for generation of pluripotent stem cells. Vitro's mission is "Harnessing the Power of Cells™" for the advancement of regenerative medicine to its full potential. Vitro operates within a modern biotechnology manufacturing, R&D and corporate facility in Golden, Colorado. Vitro manufactures and sells "Tools for Stem Cell and Drug Development™", including human mesenchymal stem cells and derivatives, optimized media for stem cell self-renewal and lineage-specific differentiation. Vitro recently formed a strategic alliance with HemoGenix�, Inc. (http://www.hemogenix.com/) to jointly manufacture and distribute Lumenesc™ and LumiSTEM™ quantitative assays for determination of stem cell quality, potency and response to toxic agents.
Safe Harbor Statement
Certain statements contained herein and subsequent statements made by and on behalf of the Company, whether oral or written may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward looking statements are identified by words such as "intends," "anticipates," "believes," "expects" and "hopes" and include, without limitation, statements regarding the Company's plan of business operations, product research and development activities, potential contractual arrangements, receipt of working capital, anticipated revenues and related expenditures. Factors that could cause actual results to differ materially include, among others, acceptability of the Company's products in the market place, general economic conditions, receipt of additional working capital, the overall state of the biotechnology industry and other factors set forth in the Company's filings with the Securities and Exchange Commission. Most of these factors are outside the control of the Company. Investors are cautioned not to put undue reliance on forward-looking statements. Except as otherwise required by applicable securities statutes or regulations, the Company disclaims any intent or obligation to update publicly these forward looking statements, whether as a result of new information, future events or otherwise.
1. Market research data provided by BCC Research.
Contact:
Vitro Diagnostics, Inc.
Dr. James Musick, 303-999-2130
Chief Executive Officer
jim@vitrodiag.com

Learn How to Invest in Gold Stocks and Mining Stocks with Free Online Investor Conference

May 2, 2011 - www.Investorideas.com and www.SmallCapVoice.com, online resources for small cap and microcap investor research, announce the current line of presenters at this May’s mining conference. Mining tocks Currie Rose Resources Inc. (TSX.V: CUI) (OTC: CUIRF) Strategic Resources (TSXV: UVR), Yale Resources Ltd. (TSX-V - YLL and Frankfurt - YAB) and Running Fox (TSX-V: RUN) (US OTC: RFXRF) (FRANKFURT: C8Q) will be presenting a 10-15 minute overview for investors.

Industry Speakers include Eric Coffin from Hard Rock Analyst, Peter Grandich, Lawrence Roulston and Stephen Whiteside of TheUpTrend.com.

The online mining conference, Follow the Money in Mining and Metals, will be held May 25th and 26. The conference is free to investors with login registration.

Learn More about the Mining Conference

Free Investor Sign-Up

Public Company Sign-Up 


Media Sponsors:

Streetwise Reports / Gold Report
Mine Snooper www.minesnooper.com and International Mining Research Inc (www.internationalminingresearch.com )

About InvestorIdeas.com: Investor Ideas that Can Change the World
Investor Ideas is a global financial media online destination specialized in sector investing content including mining and energy stocks.

About SmallCapVoice.com, Inc.: Specializing in Covering Small Cap Stocks & Providing Small Cap Investor Relations

Recognized corporate investor relations firm SmallCapVoice.com, Inc. is known for its ability to help emerging growth companies build a following among retail and institutional investors.



Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. www.InvestorIdeas.com/About/Disclaimer.asp

Disclosure: YLL is also a featured showcase stock on Investorideas.com

Learn more: http://www.investorideas.com/About/News/Clientspecifics.asp



For info on presenting as a public company, speaker or media sponsor contact



Cali Van Zant: 800-665-0411 - cvanzant@investorideas.com

Stuart T. Smith CEO

512-267-2430

ssmith@smallcapvoice.com
Source – Investorideas.com, SmallCapVoice.com

Security and Defense Stocks; Visualant Subsidiary (OTCBB:VSUL), TransTech Systems, Receives Initial Orders for Large Credentialing Project


AURORA, Ore. - May 3, 2011 (Investorideas.com Defense Newswire) - TransTech Systems, Inc., a subsidiary of Visualant, Inc. (OTCBB: VSUL), a pioneer provider of industry-leading identification solutions, is pleased to announce that it has received the initial orders for products to be used in a re-credentialing project. Credentialing is the process of establishing the qualifications of organizational members and assessing their background and legitimacy.

TransTech Systems has received the initial orders for the credentialing of all North American employees of a global security services provider. Best known for its roll in banking and retail security, this provider employs over 70,000 in approximately 100 countries. They chose one of TransTech Systems' Southwest US-based channel partners to provide the direct supplies and support for the credentialing project because of their outstanding service and commitment to meet the customer's needs.
The project will be in progress for several months as multiple locations will be rolled out. The specifics of the project have been withheld at the request of the integrator for security reasons.
About Visualant, Inc.
Visualant, Inc. (OTCBB: VSUL) develops low-cost, high speed, light-based security and quality control solutions for use in homeland security, anti-counterfeiting, forgery/fraud prevention, brand protection and process control applications. Our patent-pending technology uses controlled illumination with specific bands of light, to establish a unique spectral signature for both individual and classes of items. When matched against existing databases, these spectral signatures allow precise identification and authentication of any item or substance. This breakthrough optical sensing and data capture technology is called Spectral Pattern Matching ("SPM"). SPM technology can be miniaturized and is easily integrated into a variety of hand-held or fixed mount configurations, and can be combined in the same package as a bar-code or biometric scanner.
Through its wholly owned subsidiary, TransTech Systems, Inc., the Company provides security and authentication solutions to security and law enforcement markets throughout the United States.
Safe Harbor Statement
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: This press release contains forward-looking statements (within the meaning of Section 27a of the Securities Act of 1933 and Section 21e of the Securities Exchange Act of 1934) regarding us and our business, financial condition, results of operations and prospects. Forward-looking statements in this press release reflect the good faith judgment of our management and are based on facts and factors currently known to us. Forward-looking statements are subject to risks and uncertainties, and actual results and outcomes may differ materially from the results and outcomes discussed in the forward-looking statements as a result of either the matters set forth or incorporated in this press release generally or certain economic and business factors, some of which may be unknown to and/or beyond the control of Visualant, Inc. Specifically, we are exposed to various risks related to our need for additional financing to support our technology development, the sale of a significant number of our shares of common stock could depress the price of our common stock, acquiring or investing in new businesses and ongoing operations, we may incur losses in the future and the market price of our common stock may be volatile. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. We do not undertake, and we expressly disclaim, any obligation to revise or update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of the press release.
Contact:
Visualant, Inc.:
Lynn Felsinger
206 903 1351
Lynn@visualant.net
Investor Relations
Paul DeRiso
Core Consulting Group
925-465-6088
paul@coreconsultingroup.com
Visualant, Inc. (OTCBB:VSUL) Featured showcase company on Investorideas.com and related security portals and blogs
Visit the showcase page: http://www.investorideas.com/CO/VSUL/
Disclosure and Disclaimer: Visualant, Inc. (OTCBB:VSUL) is a paid advertising featured showcase company on Investorideas.com and related security portals and blogs.
(1500 per month and $five thousand per month in restricted 144 shares)

Nanotechnology Energy Stocks; mPhase Technologies (OTC.BB:XDSL) to Present at NJTC Energy Seminar


LITTLE FALLS, NJ - May 3, 2011 (Investorideas.com Newswire) - mPhase Technologies, Inc. (OTC.BB:XDSL) today announced that it has been invited to present at a symposium on, "Energy Storage Products and NJTC Partnering Session," at the New Jersey Institute of Technology, Newark, New Jersey, May 5, 2011, 4:30 PM -7:00 PM. At the workshop, mPhase will describe the advantages of using the Smart NanoBattery technology for powering portable electronic devices and mission critical DoD applications.

The workshop is sponsored by the New Jersey Technology Counsel, as part of an on-going series of conferences, seminars, and workshops to highlight companies in the New Jersey and Mid Atlantic region, and raise awareness of fostering cooperatives relationships among interested companies. The goal behind these individualized meetings is to discuss partnerships, collaborations and joint ventures.
"This workshop is a very good opportunity for exposing the advantages and unique capabilities of the Smart NanoBattery for forward-looking designs involving improved power efficiencies for critical systems," said Ron Durando, president and CEO of mPhase Technologies. "We are happy to support NJTC efforts in showcasing small business in New Jersey and broadening the awareness that high technology companies are a valuable asset for growing jobs the state."
About mPhase Technologies, Inc.
mPhase Technologies is introducing a revolutionary Smart Surface technology enabled by breakthroughs in nanotechnology, MEMS processing and microfluidics. Our Smart Surface technology has potential applications within drug delivery systems, lab on a chip analytic systems, self cleaning systems, liquid and chemical sensor systems, and filtration systems. mPhase has pioneered its first Smart Surface enabled product, the mPhase Smart NanoBattery.
In addition to the Smart Surface technology, mPhase recently introduced its first product, the mPower Emergency Illuminator, an award-winning product designed by Porsche Design Studio. http://www.mpowertech.com
Forward Looking Statements
As a cautionary note to investors, certain matters discussed in this press release may be forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; acceptance of the Company s products in the market; the Company s success in technology and product development; the Company s ability to execute its business model and strategic plans; and all the risks and related information described from time to time in the Company s SEC filings, including the financial statements and related information contained in the Company s SEC Filing. mPhase assumes no obligation to update the information in this release.
Contact:
mPhase Technologies, Inc. 973 256 3737

Visit the XDSL showcase profile at Investorideas.com
Request News and Info on XDSL
Disclosure, Disclaimer/ XDSL is a paid advertising client on Investorideas.com and our technology portals.

Green Car Stocks; EVCARCO, Inc. (OTCBB: EVCA) Withdraws 61 Million Share S-1 Registration With SEC; Ending Quiet Period


FT. WORTH, TX � May 3, 2011 (Investorideas.com renewable energy/green newswire) - EVCARCO, Inc. (OTCBB:EVCA) (Pinksheets:EVCA) announced today that it has withdrawn its S-1 registration statement on May 2, 2011, which has ended the quiet period.
Nikolay Frolov, Chief Financial Officer of EVCARCO, commented, "Due to this S-1 being withdrawn, the 61,225,000 shares included in this filing will not impact Authorized Shares, Outstanding Shares or the Float. Financing now being offered to the Company has much better terms."
To view this filing, please go to: http://www.sec.gov/Archives/edgar/data/1459003/000119983510000477/evcarco_s1a1.htm
Mack Sanders, CEO of EVCARCO, stated, "This S-1 was no longer the best option for the company and we have made so much progress during the quiet period, that we felt it was in our best interest to withdraw this filing instead of modifying it. This will give us the opportunity to update our shareholders on developments and at a later date we can re-file a new S-1 to take advantage of the better financing now being offered to EVCA."

For more information on EVCARCO, Inc., please view: www.evcarco.com. Shareholder inquiries should be directed to (972) 571-1624.
EVCARCO, Inc. is the first automotive retail group dedicated to deploying a coast-to-coast network of environmentally friendly franchised dealerships and vehicles. EVCARCO is bringing to market the most advanced clean technologies available in plug-in electric, alternative fuel, and pre-owned hybrid vehicles. EVCARCO -- Future Driven®
This Press Release contains certain forward-looking statements that involve substantial risks and uncertainties, including, but not limited to, the results of ongoing clinical studies, economic conditions, product and technology development, production efficiencies, product demand, competitive products, competitive environment, successful testing and government regulatory issues. Additional risks are identified in the company's filings made with the Securities and Exchange Commission.
Contact:
Investor Relations Contact:
Jack Eversull
The Eversull Group, Inc.
972-571-1624
214-469-2361 fax

Visit the EVCA showcase profile at Investorideas.com
Request News and Info on EVCA
Disclosure, Disclaimer/ EVCA is a paid advertising client on Investorideas.com and our renewable energy portals (500,000 144 shares).

Biotech and Pharma News; BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) Paving the Way for Sexual Equality for Women!


Point Roberts WA, LINCOLNSHIRE, Ill. May 3, 2011 - (Investorideas.com newswire.com) Investorideas.com, an investor research portal covering leading sectors including biotech stocks and pharma stocks, features an exclusive discussion with Mr. Stephen M. Simes, president and chief executive officer of specialty pharmaceutical company, BioSante Pharmaceuticals ( NASDAQ: BPAX ) . Mr. Simes discusses how their product LibiGel ®, (testosterone gel) for the treatment of female sexual dysfunction, paves the way for women's equality in the sexual dysfunction market, currently dominated by male products.

Women always have had to wait for their rights; from the right to vote, to equal pay and now in the treatment of sexual health matters. Stephen M. Simes discusses his personal and corporate commitment to women's health, and BioSante's objective to be first to market with a pharmaceutical product to treat women's sexual health.
In an interesting perspective from a male CEO bringing his product to market for women, Mr. Simes passionately explains the problem and the solution (LibiGel ®) that is coming to market in the not so distant future. Interestingly, BioSante's vice president of clinical development in charge of LibiGel's clinical studies is a woman!
Sexual Equality for Women!
Why is there no biotech or pharmaceutical product for the treatment of female sexual dysfunction?
By Stephen M. Simes
BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX)
Men have enjoyed access to Viagra and other erectile drugs for over 13 years.
For women, specifically women suffering from hypoactive sexual desire disorder (HSDD), product development has been notably lacking. Today in the United States there is no FDA approved pharmaceutical product for the treatment of HSDD.
Yet HSDD - lack of sexual desire - affects an untold number of women. It is more common than erectile dysfunction in men - which is a $2 billion a year prescription business in the US.
In a study by investigators the University of Chicago, of 1,400 men and 1,700 women between the ages of 18 and 59, 43% of women said they have experienced some degree of sexual dysfunction, compared with just 31% of men.  Among the women surveyed, 32% lacked interest in sex. Another study by the same group at the University also found that 43% of American women between the ages of 57 and 85 (about 40 million) experience some degree of low sexual desire.
The majority of women with female sexual dysfunction (FSD) are postmenopausal, experiencing FSD due to hormonal changes following menopause, whether natural or surgical.
Today, there is only one company in the world in active clinical development of a product for this true unmet medical need in women.  The company in development of a product is BioSante Pharmaceuticals Inc., in Lincolnshire, Illinois. The product is a transdermal testosterone gel (LibiGel ®). LibiGel currently is in Phase III clinical studies for the treatment of HSDD in post-menopausal women.  The LibiGel Phase III clinical development program includes two traditional pivotal Phase III randomized, placebo-controlled, multi-center, safety and efficacy trials, both of which are covered by an FDA SPA (special protocol assessment).
In addition, BioSante is conducting a LibiGel Phase III randomized, placebo controlled, multi-center, cardiovascular event and breast cancer safety study. Over 3,000 of a potential 4,000 women have been enrolled in the study and randomized to LibiGel or placebo. This LibiGel safety study represents the largest database of the safety of testosterone in women ever. To date, the cardiovascular event and breast cancer event rates in the study are lower than predicted. BioSante plans on submitting a new drug application (NDA) to FDA seeking approval for LibiGel by the end of 2012.
LibiGel is absorbed quickly through the skin after a once-daily pea-sized application on the upper arm, delivering testosterone to the bloodstream evenly over time and in a non-invasive and painless manner.
In a Phase II trial, LibiGel significantly increased the number of satisfying sexual events in surgically menopausal women suffering from FSD by 238 percent versus baseline (p<0.0001); this increase also was significant versus placebo (p<0.05). In this study, the effective dose of LibiGel produced testosterone blood levels within the normal range for pre-menopausal women and had a safety profile similar to that observed in the placebo group. In addition, no serious adverse events and no discontinuations due to adverse events occurred in any subject receiving LibiGel. The Phase II clinical trial was a double-blind, placebo-controlled trial, conducted in the United States, in surgically menopausal women distressed by their low sexual desire and activity.
BioSante is committed to the success of LibiGel and to women's health. The time for equal treatment of men's and women's sexuality is here. Practitioners and women are waiting for solutions.
- Stephen M. Simes is president and CEO of BioSante Pharmaceuticals Inc. (http://www.biosantepharma.com), Lincolnshire, IL.
About BioSante Pharmaceuticals, Inc.
BioSante (NASDAQ: BPAX) is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. BioSante's lead products include LibiGel ® (transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD) which is in Phase III clinical development under a U.S. Food and Drug Administration (FDA) Special Protocol Assessment. BioSante's first FDA-approved product is Elestrin™ (estradiol gel) indicated for the treatment of hot flashes associated with menopause, marketed in the U.S. by Azur Pharma, BioSante's licensee. BioSante also is developing a portfolio of cancer vaccines, four of which have been granted Orphan Drug designation, and are currently in several Phase II clinical trials. Other BioSante products are Bio-T-Gel™, a testosterone gel for male hypogonadism, for which an NDA is pending with a PDUFA date of November 14, 2011, licensed to Teva Pharmaceuticals, and an oral contraceptive in Phase II clinical development using BioSante patented technology. Additional information is available online at: www.biosantepharma.com.
For info about BioSante Pharmaceuticals, Inc
For Investors:
The Trout Group LLC
Tricia Swanson
(646) 378-2953
tswanson@troutgroup.com
or
For Media:
McKinney/Chicago
Alan Zachary
(312) 506-5220
azachary@mckinneychicago.com
Visit the company profile on Investorideas.com: http://www.investorideas.com/CO/BPAX/
Request News & Updates from BioSante (NASDAQ: BPAX) on the Investorideas.com sign up page: http://www.investorideas.com/Resources/Newsletter.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Disclaimer: The following BioSante Pharmaceuticals, Inc company profile is a paid for submission (two thousand per month) Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions, company profile submissions and online advertising. http://www.investorideas.com/About/Disclaimer.asp
Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
Forward-Looking Statements
To the extent any statements made in this news release deal with information that is not historical, these are forward-looking statements under the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about BioSante's plans, objectives, expectations and intentions with respect to future operations and products and other statements identified by words such as “will,” “potential,” “could,” “can,” “believe,” “intends,” “continue,” “plans,” “expects,” “anticipates,” “estimates,” “may,” other words of similar meaning or the use of future dates. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Uncertainties and risks may cause BioSante's actual results to be materially different than those expressed in or implied by BioSante's forward-looking statements. For BioSante, particular uncertainties and risks include, among others, the difficulty of developing pharmaceutical products, obtaining regulatory and other approvals and achieving market acceptance; the marketing success of BioSante's licensees or sublicensees; the success of clinical testing; and BioSante's need for and ability to obtain additional financing. More detailed information on these and additional factors that could affect BioSante's actual results are described in BioSante's filings with the Securities and Exchange Commission, including its most recent annual report on Form 10-K and subsequent quarterly reports on Form 10-Q. All forward-looking statements in this news release speak only as of the date of this news release. BioSante undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
Contact Investorideas.com:
C Van Zant: 800-665-0411 - cvanzant@investorideas.com
Source - Investorideas.com, BioSante

Disclosure, Disclaimer/ BPAX is a paid advertising client on Investorideas.com (1000 per month).